Interventional Radiology Imaging

What Is the Safest Central Line Site for a Patient with Kidney Disease?

·
What Is the Safest Central Line Site for a Patient with Kidney Disease?

A 68-year-old man with Stage 4 Chronic Kidney Disease (CKD) is admitted with osteomyelitis requiring a six-week course of intravenous antibiotics. He has no current dialysis access, but his nephrologist anticipates he will need an arteriovenous fistula within the next year. The admitting team needs to place a central venous catheter (CVC) for the antibiotic therapy. You know that the choice of site has long-term consequences for this patient, potentially compromising his future lifeline for dialysis. This clinical workflow article addresses the critical decision of site selection for a CVC in a patient with CKD or end-stage renal disease (ESRD). For this specific scenario, the American College of Radiology (ACR) Appropriateness Criteria rate the Right or left internal jugular vein as Usually appropriate.

Who Fits This Clinical Scenario?

This guidance applies to any patient with moderate-to-severe chronic kidney disease (CKD G3b-G5) or end-stage renal disease (ESRD), including those not yet on dialysis, who requires central venous access for indications other than immediate hemodialysis. This includes the need for long-term antibiotics, chemotherapy, or total parenteral nutrition (TPN). The core principle guiding this decision is the preservation of peripheral and central veins for future or existing hemodialysis access.

This workflow is distinct from several related scenarios:

  • Acute Renal Failure: A patient with acute kidney injury requiring temporary renal replacement therapy has different device considerations, though site selection principles often overlap. The urgency and expected duration of access can alter the risk-benefit calculation.
  • Planned Long-Term Dialysis Access: This article is not about placing a tunneled dialysis catheter (e.g., a Permacath), although the venous site selection strategy is identical. The focus here is on placing a non-dialysis CVC (e.g., a PICC, non-tunneled CVC, or tunneled CVC for other purposes) in a patient with underlying renal disease.
  • No Renal Disease: A patient with normal renal function who needs a CVC does not require the same stringent vein preservation strategy, and other sites may be considered more freely.

The defining feature of this scenario is the patient’s underlying renal dysfunction, which mandates a forward-thinking approach to every venous puncture.

What Clinical Factors Drive Site Selection?

In this scenario, the “differential diagnosis” is not a list of diseases but a set of competing clinical priorities and potential complications that drive the site selection decision. The primary goal is to choose a site that provides reliable access while minimizing harm to the patient’s future dialysis options.

Preservation of Future Dialysis Access: This is the paramount concern. The “Fistula First, Catheter Last” initiative underscores the superiority of arteriovenous fistulas (AVFs) and grafts over catheters for long-term hemodialysis. Creating a functional AVF requires healthy, patent, and undilated cephalic and basilic veins in the upper extremities. Any cannulation, especially from a peripherally inserted central catheter (PICC), can cause phlebitis, thrombosis, or scarring that renders these veins unusable for future fistula creation. Therefore, avoiding the upper extremity veins is a critical objective.

Minimizing Central Venous Stenosis: A less obvious but highly consequential risk is the development of central venous stenosis. This narrowing or occlusion of the major veins (subclavian, brachiocephalic, superior vena cava) can result from endothelial injury caused by an indwelling catheter. Subclavian vein catheters are particularly notorious for this, with high rates of stenosis that can cause debilitating arm swelling and preclude the use of that entire extremity for any future AV access.

Reducing Infection Risk: All CVCs carry a risk of catheter-related bloodstream infection (CRBSI). While technique is crucial, site selection also plays a role. Femoral vein catheters, particularly in the inpatient setting, have historically been associated with a higher risk of infection and are often less comfortable for ambulatory patients, though modern care bundles have mitigated this risk to some extent.

Why Is the Internal Jugular Vein the Recommended Site for This Presentation?

The ACR rates the Right or left internal jugular vein as Usually appropriate because it optimally balances the need for reliable central access with the absolute necessity of vein preservation in patients with CKD or ESRD. This approach directly supports the long-term clinical strategy for managing the patient’s renal failure.

The rationale is rooted in avoiding the pitfalls associated with other sites:

  • Upper extremity veins are rated Usually not appropriate. Placing a PICC line in a patient with advanced CKD is a significant clinical error. It directly jeopardizes the veins—the cephalic and basilic—that are the primary targets for future AVF creation. The risk of thrombosis or phlebitis from the PICC can permanently eliminate that arm as a viable option for dialysis access.
  • The Right or left subclavian vein is rated May be appropriate, but this rating comes with a major caveat. This site is strongly discouraged in the CKD/ESRD population due to a significantly higher incidence of central venous stenosis compared to the internal jugular approach. This stenosis can render the entire ipsilateral arm unusable for future dialysis access and can lead to severe, painful arm edema if an AVF is later created in that limb.
  • The Right or left femoral vein is also rated May be appropriate. It effectively preserves all upper extremity and thoracic central veins, making it a viable alternative if the jugular veins are inaccessible. However, it may be associated with a higher risk of infection and can limit patient mobility and comfort, making it a secondary choice for long-term ambulatory therapies.

The internal jugular approach, preferably on the right side due to its straighter path to the superior vena cava, avoids the critical upper extremity veins and has a much lower risk of causing clinically significant central stenosis than the subclavian approach. The procedure is performed under real-time ultrasound guidance, which ensures high success rates and minimizes mechanical complications. No ionizing radiation is involved.

What’s Next After Site Selection? Downstream Workflow

The decision to use the internal jugular (IJ) vein initiates a clear procedural and follow-up pathway. The first step is always a pre-procedural ultrasound assessment of the target vessel.

  • If the target IJ vein is patent and of adequate size: The clinician proceeds with ultrasound-guided placement of the appropriate CVC. Post-procedure confirmation of catheter tip position, typically via chest radiograph, is required before use.
  • If the target IJ vein is thrombosed, stenotic, or otherwise unsuitable: The next step is to perform an ultrasound assessment of the contralateral IJ vein. If it is patent and suitable, that becomes the new target site.
  • If both IJ veins are unsuitable: The situation has now escalated. The next site to consider is a common femoral vein, which is rated May be appropriate. However, if long-term access is needed, this may not be ideal. At this stage, a formal consultation with Interventional Radiology is strongly recommended. They can perform a diagnostic venogram to map the central venous anatomy and consider advanced options like translumbar or transhepatic access to the inferior vena cava, or recanalization of chronically occluded veins.

This structured, stepwise approach ensures that the least harmful options are exhausted before moving to more complex and higher-risk procedures, always prioritizing the preservation of future dialysis access.

Pitfalls to Avoid (and When to Get Help)

Navigating CVC placement in CKD patients requires vigilance to avoid common and consequential errors.

  • The “PICC-and-Forget” Pitfall: The most common error is placing a PICC line out of convenience without considering the patient’s CKD status. Always review renal function before ordering a PICC.
  • Ignoring the Subclavian Risk: Choosing a subclavian site for a non-tunneled line in an emergency without appreciating the high risk of stenosis is a critical mistake that can have lifelong consequences for the patient.
  • Skipping the Pre-procedural Ultrasound: Assuming a vein is patent without ultrasound confirmation (“blind stick”) increases the risk of multiple attempts, arterial puncture, and failure to identify chronic thrombosis.
  • Lack of Multidisciplinary Coordination: Failing to communicate with the patient’s nephrologist or vascular surgeon can lead to placing a line in a location that interferes with their long-term access plan.

If bilateral internal jugular veins are non-patent on ultrasound, escalate immediately by consulting your institution’s Interventional Radiology service for advanced assessment and access planning.

Related ACR Topics and Tools

This article covers one specific scenario in depth. For a broader view of all clinical variants and device choices, or to explore the tools used in the decision-making process, the following resources are essential.

Frequently Asked Questions

Why is the subclavian vein so strongly discouraged in patients with kidney disease?

The subclavian vein is avoided due to a high risk of causing central venous stenosis. An indwelling catheter can injure the vein wall, leading to scarring and narrowing. This can block blood flow from the arm, causing severe swelling and pain, and it permanently prevents that arm from being used for a future dialysis fistula or graft.

Can a patient with CKD or ESRD ever get a PICC line?

Placing a PICC line is almost always contraindicated in patients with CKD Stage 3b or higher, or ESRD. The procedure risks damaging the cephalic or basilic veins in the arm, which are essential for creating a future arteriovenous fistula for dialysis. Preserving these veins is a top priority. In very rare circumstances, after multidisciplinary discussion, it might be considered if no other options exist, but it is a measure of last resort.

What should be done if both internal jugular veins are occluded?

If pre-procedural ultrasound shows that both internal jugular veins are occluded, the next step is to consider an alternative site, such as the common femoral vein. However, this is an indication for an immediate consultation with Interventional Radiology. They can perform a formal venogram to map the patient’s entire venous system and may be able to perform advanced procedures like recanalizing an occluded vessel or placing a catheter via a translumbar or transhepatic route.

Does this guidance also apply to placing temporary catheters for acute hemodialysis?

Yes, the site selection principles are identical. Whether placing a temporary dialysis catheter or a CVC for another purpose, the goal in a patient with underlying CKD/ESRD is to use the internal jugular veins first to preserve upper extremity and subclavian veins for long-term access. The right internal jugular vein is the preferred site for all central catheters in this population.

Is the right internal jugular (IJ) vein preferred over the left IJ vein?

Yes, the right internal jugular vein is generally preferred. It provides a straighter, more direct path to the superior vena cava and right atrium. This anatomical advantage can lead to easier placement and may reduce the risk of catheter malfunction or vessel wall injury compared to the left-sided approach, which involves navigating a sharper turn from the left brachiocephalic vein.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026